Applied DNA Sciences Reports 14 Development Customers for its Linear DNA Manufacturing Platform
November 25th, 2019
Applied DNA Sciences Reports 14 Development Customers for its Linear DNA Manufacturing Platform
November 25th, 2019
Applied DNA Sciences Announces Closing of Upsized $12.0 Million Underwritten Public Offering
November 15th, 2019
Applied DNA Sciences Announces Pricing of Upsized $12.0 Million Underwritten Public Offering
November 13th, 2019
Successful DNA Tagging of Leather at one of the World’s Largest Tanneries
November 11th, 2019
Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors
November 8th, 2019
Applied DNA Sciences Announces 1-For-40 Reverse Stock Split
October 31st, 2019
Applied DNA Receives Notice of Allowance on Patent Protecting its CertainT® Platform in Cellulosic Fibers and Materials
October 22nd, 2019
APDN, MIT to Elevate CertainT® for Brand Assurance and Provenance
October 16th, 2019
Molecular Tagging of Pharmaceutical Excipients Utilizing Applied DNA’s Technology Published in Peer-Reviewed Journal
October 4th, 2019

Our new ticker symbol is ‘BNBX’. Learn more here.